| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |